Establishment Labs Holdings Inc (OQ:ESTA)

Business Focus: Medical Equipment, Supplies & Distribution

Apr 17, 2024 08:30 am ET
Establishment Labs Announces Participation in The Aesthetic Meeting 2024
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its participation in The Aesthetic Meeting 2024, which is being held May 2-5 in Vancouver, BC Canada.
Feb 28, 2024 04:00 pm ET
Establishment Labs Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Guidance
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced financial results for the fourth quarter and full year ended December 31, 2023 and provided 2024 guidance.
Feb 23, 2024 08:00 am ET
Establishment Labs Announces Participation in Two Upcoming Investment Conferences
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its participation in two upcoming investment conferences.
Feb 22, 2024 08:00 am ET
Establishment Labs Announces Amended Credit Facility with Oaktree
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that it has amended its $225 million term loan facility with funds managed by Oaktree Capital Management, L.P. (“Oaktree”).
Feb 14, 2024 08:00 am ET
Establishment Labs to Announce Fourth Quarter 2023 Financial Results on February 28
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended December 31, 2023, after the market closes on Wednesday, February 28, 2024, and will host a conference call at 4:30 pm ET that day to discuss those results.
Jan 22, 2024 08:00 am ET
Establishment Labs Announces Commercial Launch of Motiva Implants in China
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced it has launched Motiva® Implants in China.
Jan 09, 2024 08:06 am ET
Establishment Labs Announces $50 Million Private Placement and Preliminary Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2023
Establishment Labs Holdings Inc. (NASDAQ: ESTA) (“Establishment Labs” or the “Company”), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced it has entered into a securities purchase agreement with select institutional accredited investors to purchase common shares of the Company, or pre-funded warrants in lieu thereof. The Company also announced preliminary unaudited financial results for the fourth quarter and fiscal year 2023.
Jan 02, 2024 08:00 am ET
Establishment Labs Announces First U.S. Commercial Procedure with Motiva Flora Tissue Expander
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, announced that the Motiva Flora® SmoothSilk® Tissue Expander was used for the first time in the United States at the University of Texas MD Anderson Cancer Center in Houston by Mark Clemens, MD MBA FACS, Professor of Plastic Surgery. The recent FDA clearance and first procedure mark significant developments in the field of plastic and reconstructive surgery.
Dec 28, 2023 08:30 am ET
Establishment Labs to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced that Juan José Chacón-Quirós, Founder and Chief Executive Officer, and Raj Denhoy, Chief Financial Officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024 at 2:15 p.m. Pacific Time.
Nov 10, 2023 08:00 am ET
Establishment Labs Announces Participation in Two Upcoming Investment Conferences
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its participation in two upcoming investment conferences.
Nov 09, 2023 08:31 am ET
Thinking about buying stock in Ventyx Biosciences, Braskem SA, Lithium Americas Corp, Establishment Labs, or Xeris Biopharma Holdings?
NEW YORK, Nov. 9, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for VTYX, BAK, LAC, ESTA, and XERS.
Nov 09, 2023 08:00 am ET
Establishment Labs Announces National Medical Products Administration Approval for Motiva Implants in China
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced it has received National Medical Products Administration (NMPA) approval in China for Motiva® Implants.
Nov 07, 2023 04:00 pm ET
Establishment Labs Reports Third Quarter 2023 Financial Results
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced financial results for the third quarter ended September 30, 2023.
Oct 25, 2023 10:27 am ET
Establishment Labs to Announce Third Quarter 2023 Financial Results on November 7
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended Semptember 30, 2023, after the market closes on Tuesday, November 7, 2023, and will host a conference call at 4:30 pm ET that day to discuss those results.
Oct 16, 2023 06:00 am ET
Establishment Labs Announces FDA Clearance of Motiva Flora SmoothSilk Tissue Expander
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Motiva Flora® SmoothSilk® Tissue Expander.
Oct 13, 2023 08:00 am ET
Establishment Labs Announces Two-Year Mia Femtech Clinical Results and the Launch of Zen at 8th World Symposium on Ergonomic Implants
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, announced today both the two-year clinical results of Mia Femtech™ as well as its launch of Zen™, the Company’s next generation RFID technology, at the 8th Annual World Symposium on Ergonomic Implants (WSEI) being held this week in Lisbon, Portugal.
Aug 08, 2023 04:00 pm ET
Establishment Labs Reports Record Second Quarter 2023 Financial Results
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced financial results for the second quarter ended June 30, 2023.
Jul 26, 2023 08:00 am ET
Establishment Labs to Announce Second Quarter 2023 Financial Results on August 8
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended June 30, 2023, after the market closes on Tuesday, August 8, 2023, and will host a conference call at 4:30 pm ET that day to discuss those results.
Jul 19, 2023 08:00 am ET
Establishment Labs Celebrates Opening of Sulàyöm Innovation Campus and Outlines New and Expanded Capabilities
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced the grand opening of the Sulàyöm Innovation Campus in the Coyol Free Zone, Costa Rica.
May 31, 2023 08:00 am ET
Establishment Labs to Participate in Two Upcoming Investor Conferences
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its participation in two upcoming investor conferences.
May 30, 2023 08:00 am ET
Establishment Labs Announces CE Mark Approval for Minimally Invasive Surgical Tools
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced it has received CE marking under the European Medical Device Regulation for the Motiva Injector®, the Motiva® Inflatable Balloon, and the Motiva® Channel Dissector.
May 08, 2023 04:00 pm ET
Establishment Labs Reports Record First Quarter 2023 Financial Results
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced financial results for the first quarter ended March 31, 2023.
Apr 27, 2023 10:30 am ET
Establishment Labs Announces Closing of Public Offering of Common Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Establishment Labs Holdings Inc. (Nasdaq: ESTA) (the “Company”), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced the closing of its previously announced public offering of 1,265,000 common shares at $71.50 per share. This includes the exercise in full by the underwriters of their option to purchase up to 165,000 additional common shares. The gross proceeds to the Company were approximately $90.4 million, before deducting the underwriting discounts and commissions and estimated offering
Apr 26, 2023 08:00 am ET
Establishment Labs to Announce First Quarter 2023 Financial Results on May 8
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended March 31, 2023 after the market closes on Monday, May 8, 2023, and will host a conference call at 4:30 pm ET that day to discuss those results.
Apr 24, 2023 11:46 pm ET
Establishment Labs Announces Pricing of Public Offering of Common Shares
Establishment Labs Holdings Inc. (NASDAQ: ESTA) (the “Company”), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced the pricing of its public offering of 1,100,000 common shares at a price of $71.50 per share. The gross proceeds to Establishment Labs, before deducting the underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $78.7 million. The offering is scheduled to close on April 27, 2023, subject to the satisfaction of customary closin
Apr 24, 2023 04:44 pm ET
Establishment Labs Announces Proposed Public Offering of Common Shares
Establishment Labs Holdings Inc. (NASDAQ: ESTA) (the “Company”), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced that it has commenced a public offering of its common shares, to be sold by the Company in a registered public offering. The Company expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the common shares to be sold in the proposed offering, at the public offering price per share, less underwriting discounts and commissions. The offering is
Apr 24, 2023 04:41 pm ET
Establishment Labs Announces Preliminary Unaudited Results for First Quarter 2023
Establishment Labs Holdings Inc. (NASDAQ: ESTA) (the “Company”), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced preliminary unaudited financial results for the first quarter of 2023.
Apr 20, 2023 03:25 pm ET
Establishment Labs Notes Presentation of 3-Year Results from Motiva U.S. IDE Study at The Aesthetic Meeting 2023
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today noted the presentation of a study update on the Motiva US IDE Study. The update included three-year patient follow-up data for primary augmentation subjects. The Medical Director of the Study, Dr. Caroline Glicksman, who is also a Principal Investigator in the Study, presented the results today at Aesthetic Surgery Education and Research Foundation (ASERF) Premier Global Hot Topics session as part of
Apr 10, 2023 04:30 pm ET
Establishment Labs Begins a New Era in Breast Aesthetics with Launch of Mia Femtech in Japan
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced the launch of Mia Femtech™ (“Mia®”) in Japan, marking the beginning of a new era in breast aesthetics.
Apr 03, 2023 08:00 am ET
Establishment Labs Announces Participation in The Aesthetic Meeting 2023
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its participation in The Aesthetic Meeting 2023, which is being held April 19-23 in Miami, Florida.
Mar 29, 2023 08:00 am ET
Establishment Labs Surpasses Three Million Motiva Devices
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, announced that it has surpassed three million Motiva® devices in market.
Mar 23, 2023 08:00 am ET
Establishment Labs Announces First Mia Femtech™ Partners in Europe and Second Partner Chain in Japan
Establishment Labs Holdings Inc. (Nasdaq: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced it has entered into agreements with four partners in Europe and a second partner chain in Japan for Mia Femtech™ (“Mia®”).
Mar 02, 2023 12:30 pm ET
ESTA INVESTOR NOTICE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Establishment Labs Holdings Inc. Investors to Inquire About Securities Class Action Investigation – ESTA
WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Establishment Labs Holdings Inc. (NASDAQ: ESTA) resulting from allegations that the Company may have issued materially misleading business information to the investing public.
Feb 28, 2023 08:00 am ET
Establishment Labs to Present at the Cowen 43rd Annual Health Care Conference
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced that Juan José Chacón-Quirós, Founder and Chief Executive Officer, and Raj Denhoy, Chief Financial Officer, will present at the Cowen 43rd Annual Health Care Conference on Tuesday, March 7, 2023, at 9:50 am Eastern Time.
Feb 27, 2023 04:00 pm ET
Establishment Labs Submits Module Four to U.S. FDA for Premarket Approval of Motiva and Reports Record Fourth Quarter and Full Year 2022 Financial Results
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced that it has submitted the fourth and final module of its modular submission to the FDA for premarket approval of Motiva Implants® in the United States. The company also provided unaudited financial results for the fourth quarter and full year ended December 31, 2022 and provided 2023 guidance.
Feb 13, 2023 08:00 am ET
Establishment Labs to Announce Fourth Quarter 2022 Financial Results on February 27
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended December 31, 2022, after the market closes on Monday, February 27, 2023, and will host a conference call at 4:30 pm ET that day to discuss those results.
Jan 09, 2023 08:00 am ET
Establishment Labs Announces Preliminary Unaudited Revenue for Fourth Quarter and Fiscal Year 2022
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced preliminary unaudited revenue for the three months and fiscal year ended December 31, 2022.
Jan 03, 2023 08:03 am ET
Establishment Labs Announces Seishin Plastic and Aesthetic Surgery Clinic in Japan as First Clinic Partner in Global Launch of Mia Femtech™
Establishment Labs Holdings Inc. (Nasdaq: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced it has entered into an agreement with Seishin Plastic and Aesthetic Surgery Clinic in Japan for Mia Femtech™ (“Mia®”).
Dec 29, 2022 09:00 pm ET
ESTABLISHMENT LABS ALERT: Bragar Eagel & Squire, P.C. is Investigating Establishment Labs Holdings Inc. on Behalf of Establishment Labs Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Establishment Labs Holdings Inc. (“Establishment Labs” or the “Company”) (NASDAQ: ESTA) on behalf of Establishment Labs...
Dec 28, 2022 08:00 am ET
Establishment Labs to Participate in 41st Annual J.P. Morgan Healthcare Conference
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced that Juan José Chacón-Quirós, Founder and Chief Executive Officer, will present at the 41st Annual J.P. Morgan Healthcare Conference on Thursday, January 12 at 7:30 a.m. Pacific Time.
Nov 21, 2022 08:45 pm ET
Bragar Eagel & Squire, P.C. Is Investigating EyePoint, F45, PROG, and Establishment and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), F45 Training Holdings, Inc. (NYSE: FXLV), PROG Holdings, Inc. (NYSE: PRG),...
Nov 17, 2022 12:50 pm ET
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Establishment Labs Holdings (ESTA) Investors to Contact the Firm’s Attorneys, Firm Investigating Possible Securities Law Violations
Hagens Berman urges Establishment Labs Holdings Inc. (NASDAQ: ESTA) investors who suffered significant losses to submit your losses now. The firm is investigating possible securities law violations. Visit:...
Nov 14, 2022 01:02 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Establishment Labs Holdings Inc. - ESTA
NEW YORK, Nov. 14, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  Establishment Labs Holdings Inc. ("Establishment Labs" or the "Company") (NASDAQ: ESTA).  Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
Nov 11, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Is Investigating Establishment, Accelerate Diagnostics, Instil and Unisys and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Establishment Labs Holdings Inc. (NASDAQ: ESTA), Accelerate Diagnostics, Inc. (NASDAQ: AXDX), Instil Bio, Inc. (NASDAQ:...
Nov 10, 2022 08:00 am ET
Establishment Labs Announces Japanese Regulatory Approval and Reimbursement for Motiva Implants and the Motiva Flora Tissue Expander for Use in Post-Mastectomy Reconstruction
Establishment Labs Holdings Inc. (Nasdaq: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced Motiva Implants® and the Motiva Flora® tissue expander have been approved for use in Japan by the Pharmaceuticals and Medical Devices Agency (PMDA). The products have also received reimbursement for post-mastectomy reconstruction under the Japanese National Health System. The first reconstruction patient in Japan was successfully treated with Motiva in ear
Nov 07, 2022 04:49 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Establishment Labs Holdings Inc. - ESTA
Pomerantz LLP is investigating claims on behalf of investors of Establishment Labs Holdings Inc. (“Establishment Labs” or the “Company”) (NASDAQ: ESTA). Such investors are advised to contact Robert S. Willoughby at [email protected] or...
Nov 07, 2022 04:00 pm ET
Establishment Labs Reports Third Quarter 2022 Financial Results
Establishment Labs Holdings Inc. (Nasdaq: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its financial results for the third quarter ended September 30, 2022.
Nov 07, 2022 10:18 am ET
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Establishment Labs Holdings (ESTA) Investors to Contact the Firm’s Attorneys, Firm Investigating Possible Securities Law Violations
Hagens Berman urges Establishment Labs Holdings Inc. (NASDAQ: ESTA) investors who suffered significant losses to submit your losses now. The firm is investigating possible securities law violations. Visit:...
Nov 06, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Is Investigating PROG, Tattooed Chef, and Establishment and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against PROG Holdings, Inc. (NYSE: PRG), Tattooed Chef, Inc. (NASDAQ: TTCF), and Establishment Labs Holdings Inc. (NASDAQ: ESTA)....
Nov 04, 2022 01:00 am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Establishment Labs Holdings Inc. - ESTA
NEW YORK, Nov. 4, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  Establishment Labs Holdings Inc. ("Establishment Labs" or the "Company") (NASDAQ: ESTA).  Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
Nov 02, 2022 03:38 pm ET
ESTA INVESTIGATION: Hagens Berman, National Trial Attorneys, Encourages Establishment Labs Holdings (ESTA) Investors to Contact the Firm’s Attorneys, Firm Investigating Possible Securities Law Violati
Hagens Berman urges Establishment Labs Holdings Inc. (NASDAQ: ESTA) investors who suffered significant losses to submit your losses now. The firm is investigating possible securities law violations. Visit: www.hbsslaw.com/investor-fraud/ESTAContact...
Nov 01, 2022 08:00 am ET
Establishment Labs Announces Participation in Two Upcoming Investment Conferences
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its participation in two upcoming investment conferences.
Oct 31, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Is Investigating Establishment, FIGS, and Accelerate Diagnostics and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Establishment Labs Holdings Inc. (NASDAQ: ESTA), FIGS, Inc. (NYSE: FIGS), and Accelerate Diagnostics, Inc. (NASDAQ: AXDX)....
Oct 26, 2022 09:45 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Establishment Labs Holdings Inc. - ESTA
NEW YORK, Oct. 26, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Establishment Labs Holdings Inc. ("Establishment Labs" or the "Company") (NASDAQ: ESTA). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
Oct 26, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Is Investigating Establishment, FIGS, and Accelerate Diagnostics and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Establishment Labs Holdings Inc. (NASDAQ: ESTA), FIGS, Inc. (NYSE: FIGS), and Accelerate Diagnostics, Inc. (NASDAQ: AXDX)....
Oct 25, 2022 08:36 pm ET
ROSEN, A LEADING LAW FIRM, Encourages Establishment Labs Holdings Inc. Investors to Inquire About Securities Class Action Investigation – ESTA
WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Establishment Labs Holdings Inc. (NASDAQ: ESTA) resulting from allegations that the Company may have...
Oct 25, 2022 04:56 pm ET
ESTA ALERT: Hagens Berman, National Trial Attorneys, Encourages Establishment Labs Holdings (ESTA) Investors to Contact the Firm’s Attorneys, Firm Investigating Possible Securities Law Violations
Hagens Berman urges Establishment Labs Holdings Inc. (NASDAQ: ESTA) investors who suffered significant losses to submit your losses now. The firm is investigating possible securities law violations. Visit:...
Oct 25, 2022 04:49 am ET
Establishment Labs Holdings Inc. Investors: Please contact the Portnoy Law Firm to recover your losses
​The Portnoy Law Firm advises Establishment Labs Holdings Inc. (NASDAQ: ESTA) investors that the law firm has initiated an investigation on behalf of investors that lost money on their Establishment Labs' stock. Establishment Labs' investors are...
Oct 24, 2022 08:00 am ET
Establishment Labs to Announce Third Quarter 2022 Financial Results on November 7
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended September 30, 2022 after the market closes on Monday, November 7, 2022, and will host a conference call at 4:30 pm ET that day to discuss those results.
Oct 24, 2022 04:30 am ET
INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Establishment Labs Holdings Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / October 24, 2022 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Establishment Labs Holdings Inc. ("Establishment Labs" or "the Company") (NASDAQ:ESTA) for violations of the securities laws.
Oct 22, 2022 01:48 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Establishment Labs Holdings Inc. - ESTA
Pomerantz LLP is investigating claims on behalf of investors of Establishment Labs Holdings Inc. (“Establishment Labs” or the “Company”) (NASDAQ: ESTA).   Such investors are advised to contact Robert S. Willoughby at [email protected] or...
Oct 21, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Is Investigating Hannon, Flagstar, Establishment, and FIGS and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Hannon Armstrong Sustainable Infrastructure Capital, Inc. (NYSE: HASI), Flagstar Bancorp, Inc. (NYSE: FBC), Establishment...
Oct 20, 2022 09:00 pm ET
ESTABLISHMENT LABS ALERT: Bragar Eagel & Squire, P.C. is Investigating Establishment Labs Holdings Inc. on Behalf of Establishment Labs Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Establishment Labs Holdings Inc. (“Establishment Labs” or the “Company”) (NASDAQ: ESTA) on behalf of Establishment Labs stockholders. Our investigation concerns whether Establishment Labs has violated the federal securities laws and/or engaged in other unlawful business practices.
Oct 20, 2022 08:30 pm ET
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Establishment Labs Holdings Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / October 20, 2022 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Establishment Labs Holdings Inc. ("Establishment Labs" or "the Company") (NASDAQ:ESTA) for violations of the securities laws.
Oct 20, 2022 09:11 am ET
ESTA INVESTOR ALERT: Hagens Berman, National Trial Attorneys, Encourages Establishment Labs Holdings (ESTA) Investors to Contact the Firm's Attorneys, Firm Investigating Possible Securities Law Violat
SAN FRANCISCO, Oct. 20, 2022 /PRNewswire/ -- Hagens Berman urges Establishment Labs Holdings Inc. (NASDAQ: ESTA) investors who suffered significant losses to submit your losses now. The firm is investigating possible securities law violations.
Oct 20, 2022 09:11 am ET
INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Establishment Labs Holdings Inc. with Losses of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Establishment Labs Holdings Inc. (“Establishment Labs” or “the Company”) (NASDAQ:
Oct 19, 2022 05:56 pm ET
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Establishment Labs Holdings (ESTA) Investors to Contact the Firm’s Attorneys, Firm Investigating Possible Securities Law Violations
Hagens Berman urges Establishment Labs Holdings Inc. (NASDAQ: ESTA) investors who suffered significant losses to submit your losses now. The firm is investigating possible securities law violations. Visit:...
Oct 19, 2022 02:41 pm ET
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Establishment Labs Holdings Inc. with Losses of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Establishment Labs Holdings Inc. (“Establishment Labs” or “the Company”) (NASDAQ:
Oct 19, 2022 12:36 pm ET
EQUITY ALERT: Rosen Law Firm Encourages Establishment Labs Holdings Inc. Investors with Losses in Excess of $100K to Inquire About Securities Class Action Investigation – ESTA
WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Establishment Labs Holdings Inc. (NASDAQ: ESTA) resulting from allegations that the Company may have issued materially misleading business information to the investing public.
Oct 19, 2022 12:02 pm ET
Establishment Labs Shareholder News: Johnson Fistel Encourages ESTA Shareholders with Losses to Contact the Firm Regarding Investigation
Shareholder rights law firm Johnson Fistel, LLP (www.JohnsonFistel.com) is investigating whether Establishment Labs Holdings Inc. ("Establishment Labs" or the "Company") (NASDAQ: ESTA), any of its executive officers, or others violated securities...
Oct 19, 2022 10:00 am ET
Establishment Labs Holdings Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm
Block & Leviton is investigating Establishment Labs Holdings, Inc. (NASDAQ: ESTA) for potential securities law violations. Investors who have lost money in their Establishment Labs Holdings, Inc. investment should contact the firm to learn more...
Sep 20, 2022 04:30 pm ET
Establishment Labs to Host Investor Event for Mia Femtech on October 5, 2022
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that it will host an investor event on October 5, 2022 to discuss Mia Femtech® (“Mia”). A webcast of the event will begin at 4:30 p.m. Eastern Time.
Sep 12, 2022 08:00 am ET
Establishment Labs Announces Hani Zeini has Joined the Company as Exclusive Advisor in Anticipation of US Launch
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that it has retained Hani Zeini to an exclusive, multiyear advisory contract in anticipation of its US commercial launch.
Aug 08, 2022 04:00 pm ET
Establishment Labs Reports Record Second Quarter 2022 Financial Results
Establishment Labs Holdings Inc. (Nasdaq: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its financial results for the second quarter ended June 30, 2022.
Aug 03, 2022 08:00 am ET
Establishment Labs Announces Complete Enrollment in Motiva US IDE Study
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced it has completed enrollment in the Motiva US IDE clinical study. The final surgery in the primary reconstruction cohort was completed at Northwestern Memorial Hospital. The Augmentation cohort, which finished enrollment in August of 2019, will complete its third year of study follow-up this month.
Jul 25, 2022 08:00 am ET
Establishment Labs to Announce Second Quarter 2022 Financial Results on August 8
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended June 30, 2022 after the market closes on Monday, August 8, 2022, and will host a conference call at 4:30 pm ET that day to discuss those results.
Jul 19, 2022 08:00 am ET
Establishment Labs Releases 2021 Sustainability Review
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced publication of its 2021 Sustainability Review to coincide with the fourth anniversary of the company’s public listing on NASDAQ.
Jun 06, 2022 08:00 am ET
Establishment Labs to Present at the Jefferies Healthcare Conference
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced that Juan José Chacón-Quirós, Founder and Chief Executive Officer, and Raj Denhoy, Chief Financial Officer, will present at the Jefferies Healthcare Conference on Wednesday, June 8, 2022 at 10:30 am Eastern Time.
May 09, 2022 04:00 pm ET
Establishment Labs Reports Record First Quarter 2022 Financial Results
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its financial results for the first quarter ended March 31, 2022.
Apr 28, 2022 08:00 am ET
Establishment Labs to Announce First Quarter 2022 Financial Results on May 9
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended March 31, 2022 after the market closes on Monday, May 9, 2022, and will host a conference call at 4:30 pm ET that day to discuss those results.
Apr 26, 2022 08:09 am ET
Establishment Labs Enters Into $225 Million Credit Facility With Oaktree
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that it has entered into a $225 million term loan financing facility with funds managed by Oaktree Capital Management, L.P. (“Oaktree”).
Apr 21, 2022 06:54 pm ET
Establishment Labs Notes Presentation of 2-Year Results from Motiva US IDE Study at The Aesthetic Meeting 2022
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today noted the presentation of interim study data from the augmentation cohort of its Motiva US IDE Study. This Study Update includes two-year patient follow-up data for primary augmentation subjects. The Medical Director of the Study, Dr. Caroline Glicksman, who is also a Principal Investigator in the Study, is presenting the results today at The Aesthetic Meeting 2022 in San Diego, California.
Apr 11, 2022 08:00 am ET
Establishment Labs Announces Participation in The Aesthetic Meeting 2022 and Sessions of Interest
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced its participation in The Aesthetic Meeting 2022, which is being held April 20-24 in San Diego, California, as well as sessions of interest at the meeting.
Mar 02, 2022 08:00 am ET
Establishment Labs to Present at the Cowen 42nd Annual Health Care Conference
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced that Juan José Chacón-Quirós, Founder and Chief Executive Officer, and Raj Denhoy, Chief Financial Officer, will present virtually at the Cowen 42nd Annual Health Care Conference on Monday, March 7, 2022 at 2:10 pm Eastern Time.
Mar 01, 2022 08:00 am ET
Establishment Labs Reports Fourth Quarter and Full Year 2021 Financial Results; Record Fourth Quarter Revenue of $35.3 Million
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its financial results for the fourth quarter and full year ended December 31, 2021 and provided initial 2022 guidance.
Feb 17, 2022 08:00 am ET
Establishment Labs Reaches Two Million Motiva Implants Milestone
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, announced that it has surpassed two million Motiva Implants® in market.
Feb 15, 2022 08:00 am ET
Establishment Labs to Announce Fourth Quarter 2021 Financial Results on March 1
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended December 31, 2021 before the market opens on Tuesday, March 1, 2022, and will host a conference call at 8:30 am ET that day to discuss those results.
Jan 10, 2022 08:00 am ET
Establishment Labs Announces Preliminary Fourth Quarter and Fiscal Year 2021 Revenue
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today reported preliminary unaudited revenue for the three months and fiscal year ended December 31, 2021.
Jan 03, 2022 08:00 am ET
Establishment Labs to Present at the 40th Annual J.P. Morgan Healthcare Conference
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced that Juan José Chacón-Quirós, Founder and Chief Executive Officer, will present at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022 at 1:30pm Eastern Time.
Dec 13, 2021 08:00 am ET
Establishment Labs Announces Appointment of Raj Denhoy as Chief Financial Officer
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced the appointment of Raj Denhoy as Chief Financial Officer effective immediately. Mr. Denhoy has been with the company since February 2021, including as Interim Chief Financial Officer since August.
Dec 10, 2021 08:00 am ET
Establishment Labs Announces Appointment of Leslie Gillin to Board of Directors
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced the appointment of Leslie Gillin to its Board of Directors, effective immediately.
Nov 24, 2021 08:00 am ET
Establishment Labs Announces Participation in the Stephens Annual Investment Conference
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced that Juan José Chacón-Quirós, Founder and Chief Executive Officer, and Raj Denhoy, Interim Chief Financial Officer and Head of Strategy and Investor Relations, will participate in the Stephens Annual Investment Conference, which is being held December 1-3, 2021. Mr. Chacón-Quirós and Mr. Denhoy are scheduled to speak in-person to conference attendees at 1:00 pm CT on Thursday, December 2, 20
Nov 11, 2021 08:00 am ET
Establishment Labs Announces Participation in Two Upcoming Investment Conferences
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its participation in two upcoming investment conferences.
Nov 09, 2021 08:00 am ET
Establishment Labs Reports Third Quarter 2021 Financial Results and Raises Full Year Guidance
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its financial results for the third quarter ended September 30, 2021 and provided updated 2021 guidance.
Nov 05, 2021 08:00 am ET
Establishment Labs Announces Jeffrey Bettinger Has Joined the Company as Global Head of People
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, announced today that Jeffrey Bettinger has been appointed Global Head of People.
Oct 26, 2021 08:00 am ET
Establishment Labs to Announce Third Quarter 2021 Financial Results on November 9
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended September 30, 2021, before the market opens on Tuesday, November 9, 2021, and will host a conference call at 8:30 am ET that day to discuss those results.
Oct 14, 2021 08:00 am ET
Establishment Labs Launches JOY™
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced the launch of JOY™, a new patient-centric breast aesthetics program. Women who select JOY will receive Establishment Labs’ newest generation Motiva Ergonomix2® implants through a network of highly trained plastic surgeons as well as the most comprehensive patient support program available in the industry. JOY is being unveiled at the 6th World Symposium on Er
Sep 30, 2021 04:30 pm ET
Establishment Labs Announces Events for Pink October and Breast Cancer Awareness Month
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced the events and activities planned for the month of October in support of Pink October and Breast Cancer Awareness Month.
Sep 02, 2021 01:53 pm ET
Establishment Labs Launches Motiva Flora Tissue Expander in Europe and Other CE Mark Countries
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, held a symposium at the London Breast Meeting on Thursday, September 2, 2021, marking the official launch of the company’s Motiva Flora® tissue expander in Europe and other CE Mark countries.
Aug 20, 2021 08:00 am ET
Establishment Labs to Launch Motiva Flora Tissue Expander at London Breast Meeting on September 2, 2021
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced it will host an event on September 2, 2021 marking the official launch of the company’s Motiva Flora® tissue expander in Europe and other CE Mark countries. Motiva Flora offers several notable advances, including Establishment Labs’ patented SmoothSilk® surface technology as well as an RFID enabled non-magnetic integrated port, that offer potential improvements in imagi
Aug 11, 2021 06:35 pm ET
CORRECTING and REPLACING Establishment Labs Announces Participation in the UBS Genomics 2.0 and MedTech Innovations Summit
Presentation time in the release dated August 2, 2021, should read 8:00 am PT on Thursday, August 12, 2021 (instead of 8 am ET).
Aug 02, 2021 08:00 am ET
Eko Appoints Renee Gaeta as Chief Financial Officer
Eko, a cardiopulmonary digital health company, today announced the appointment of Renee Gaeta as Chief Financial Officer (CFO) and member of the executive leadership team. “Eko is at a key moment in its journey to build a comprehensive platform...
Aug 02, 2021 08:00 am ET
Establishment Labs Announces Participation in the UBS Genomics 2.0 and MedTech Innovations Summit
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced that Juan José Chacón-Quirós, Chief Executive Officer and Founder, and Raj Denhoy, Interim Chief Financial Officer and Head of Strategy and Investor Relations, will participate in the UBS Genomics 2.0 and MedTech Innovations Summit, which is being held August 10-12, 2021. Mr. Chacón-Quirós and Mr. Denhoy are scheduled to speak to conference attendees at 8:00 am ET on Thursday, August 12, 202
Jul 29, 2021 08:00 am ET
Establishment Labs Reports Record Second Quarter 2021 Financial Results and Raises Full Year Guidance
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its financial results for the second quarter ended June 30, 2021 and provided updated 2021 guidance.
Jul 20, 2021 04:05 pm ET
Establishment Labs Releases 2020 Corporate Social Responsibility Annual Review
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced publication of its 2020 Corporate Social Responsibility annual review to coincide with the third anniversary of the company’s public listing on NASDAQ.
Jul 16, 2021 08:00 am ET
Establishment Labs to Announce Second Quarter 2021 Financial Results on July 29
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, plans to announce its financial results for the quarter ended June 30, 2021, before the market opens on Thursday, July 29, 2021, and will host a conference call at 8:30 am ET that day to discuss those results.
Jul 15, 2021 08:00 am ET
Establishment Labs Announces Appointment of Ann Custin and Bryan Slotkin to Board of Directors
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced the appointment of Ann Custin and Bryan Slotkin to its Board of Directors, effective immediately.
Jul 12, 2021 08:00 am ET
Establishment Labs Announces Departure of CFO and Appointment of Raj Denhoy as Interim CFO
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that Renee Gaeta will step down from her position as Chief Financial Officer for another opportunity outside of the company, effective July 30, 2021 and following the planned release of the company’s second quarter financial results. Raj Denhoy, Head of Strategy and Investor Relations, has been named Interim Chief Financial Officer effective upon Mrs. Gaeta’s departure.
Jun 23, 2021 03:04 pm ET
Establishment Labs Breaks Ground on Third Facility, Preparing to Expand Capabilities in Manufacturing, R&D, and Medical Education
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today held the groundbreaking ceremony for its new Sulayöm Innovation Campus in Costa Rica. When complete, the new facilities will total approximately 145,000 square feet (13,500 square meters) and will support the company’s continued global growth with additional capacity and capabilities in manufacturing, R&D, digital media, training, and medical education.
Jun 23, 2021 01:00 pm ET
Establishment Labs Breaks Ground on Third Facility, Preparing to Expand Capabilities in Manufacturing, R&D, and Medical Education
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today held the groundbreaking ceremony for its new SulayIöm Innovation Campus in Costa Rica. When complete, the new facilities will total approximately 145,000 square feet (13,500 square meters) and will support the company’s continued global growth with additional capacity and capabilities in manufacturing, R&D, digital media, training, and medical education.
Jun 21, 2021 11:05 am ET
Establishment Labs Announces Publication of Landmark Breast Implant Surface Research in Nature Biomedical Engineering
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced results from a landmark study investigating how different breast implant surfaces affect the host immune response. The purpose of the study was to determine the optimal breast implant surface topography that induces the least amount of adverse foreign-body response and understand better how breast implant design impacts biocompatibility.
Jun 01, 2021 08:00 am ET
Establishment Labs Announces Appointments of Heather Brennan as Head of U.S. Commercial Operations and Neeta Toprani as General Counsel & Corporate Secretary
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, announced today that Heather Brennan has joined the company as Head of U.S. Commercial Operations and Neeta Toprani has joined as General Counsel & Corporate Secretary.
May 25, 2021 08:00 am ET
Establishment Labs Announces Participation in the Jefferies Virtual Healthcare Conference
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that CEO and Founder Juan José Chacón-Quirós and Chief Financial Officer Renee Gaeta will participate in the Jefferies Virtual Healthcare Conference, which is being held June 1-4, 2021. Mr. Chacón-Quirós and Mrs. Gaeta are scheduled to speak to conference attendees at 2:00 pm ET on Friday, June 4, 2021.
May 18, 2021 08:00 am ET
Establishment Labs Announces Pratip Dastidar Has Joined the Company as Head of Global Operations
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, announced today that Pratip Dastidar has been appointed Head of Global Operations.
May 11, 2021 08:00 am ET
Establishment Labs Announces Participation in the UBS Global Healthcare Virtual Conference
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that CEO and Founder Juan José Chacón-Quirós and Chief Financial Officer Renee Gaeta will participate in the UBS Global Healthcare Virtual Conference, which is being held May 24-26, 2021. Mr. Chacón-Quirós and Mrs. Gaeta are scheduled to speak to conference attendees at 9:00 am ET on Monday, May 24, 2021.
May 05, 2021 08:00 am ET
Establishment Labs Reports Record First Quarter 2021 Financial Results and Raises Full Year Guidance
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced its financial results for the first quarter ended March 31, 2021 and provided updated 2021 guidance.
Apr 27, 2021 08:00 am ET
Establishment Labs Completes Enrollment of One Hundred Patient Motiva Mia IRB Study
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced it has completed enrollment in its one hundred patient Motiva Mia® case series in Costa Rica. The Institutional Review Board (IRB) approved study began in December 2020 and follows the initial 2019 case series in Asia. Establishment Labs also announced that is has submitted the tools used in the Motiva Mia® breast enhancement procedure for CE mark.
Apr 14, 2021 08:00 am ET
Establishment Labs to Announce First Quarter 2021 Financial Results on May 5
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, plans to announce its financial results for the quarter ended March 31, 2021 before the market opens on Wednesday, May 5, 2021, and will host a conference call at 8:30 am ET that day to discuss those results.
Mar 10, 2021 08:00 am ET
Establishment Labs Reports Fourth Quarter and Full Year 2020 Financial Results; Record Fourth Quarter Revenue of $27.0 Million
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced its financial results for the fourth quarter and full year ended December 31, 2020 and provided initial 2021 guidance.
Feb 24, 2021 08:05 am ET
Establishment Labs Announces Raj Denhoy Has Joined the Company as Head of Strategy and Investor Relations
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, announced today that Raj Denhoy has been appointed Head of Strategy and Investor Relations.
Feb 24, 2021 08:00 am ET
Establishment Labs to Announce Fourth Quarter 2020 Financial Results on March 10
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, plans to announce its financial results for the quarter ended December 31, 2020 before the market opens on Wednesday, March 10, 2021, and will host a conference call at 8:30 am ET that day to discuss those results.
Feb 16, 2021 08:00 am ET
Establishment Labs Announces Participation in the Cowen 41st Annual Healthcare Conference
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that CEO and Founder Juan José Chacón-Quirós and Chief Financial Officer Renee Gaeta will participate in the Cowen 41st Annual Healthcare Conference, which is being held March 1-4, 2021. Mr. Chacón-Quirós and Mrs. Gaeta are scheduled to speak to conference attendees at 9:50 am ET on Tuesday, March 2, 2021.
Feb 09, 2021 08:00 am ET
Establishment Labs Hosts Investor Event for its Motiva MIA® System for Minimally Invasive Augmentation
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, is hosting a virtual investor event today, February 9, 2021, 1:00 - 2:30 p.m. ET to discuss its Motiva MIA system for minimally invasive breast augmentation.
Feb 03, 2021 08:00 am ET
Establishment Labs Announces Participation in the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that CEO and Founder Juan José Chacón-Quirós and Chief Financial Officer Renee Gaeta will participate in the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference, which is being held February 17-19, 2021. Mr. Chacón-Quirós and Mrs. Gaeta are scheduled to speak to conference attendees at 10:00 am ET on Friday, February 19, 2021.
Jan 21, 2021 08:15 am ET
Establishment Labs to Host Investor Event Featuring Its Motiva Mia System
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced it will host a virtual investor event on Feb. 9, 2021 to discuss its Motiva Mia® system for minimally invasive augmentation, which includes the Motiva Ergonomix2 Diamond® breast implant.
Jan 13, 2021 08:00 am ET
Establishment Labs Announces Participation in the 39th Annual J.P. Morgan Healthcare Conference
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that CEO and Founder Juan José Chacón-Quirós will participate in the 39th Annual J.P. Morgan Healthcare Conference, which is being held January 11-14, 2021. Mr. Chacón-Quirós is scheduled to speak to conference attendees at 4:30 pm ET on Thursday, January 14, 2021.
Jan 11, 2021 08:15 am ET
Establishment Labs Reports Preliminary Results for Fourth Quarter and Fiscal Year 2020
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today reported preliminary revenue and cash figures for the fourth quarter and fiscal year ended December 31, 2020.
Dec 14, 2020 08:00 am ET
Motiva Ergonomix2 Platform and Motiva Mia Implant Receive CE Mark
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced it has received a CE mark for its next generation Motiva...
Dec 10, 2020 08:00 am ET
Establishment Labs Completes 21 Motiva Mia Patients in IRB Approved Study in Costa Rica
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced it recently received Institutional Review Board (IRB) approval to...
Nov 10, 2020 08:00 am ET
Establishment Labs to Participate in Two Upcoming Investment Conferences
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced its participation in two investment conferences this month....
Nov 09, 2020 04:05 pm ET
Establishment Labs Reports Third Quarter 2020 Financial Results
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced its financial results for the third quarter ended September 30,...
Oct 21, 2020 08:00 am ET
Establishment Labs Reports Preliminary Third Quarter Revenue and Cash Balance
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today reported strong preliminary revenue and cash figures for the quarter ended...
Oct 21, 2020 08:00 am ET
Establishment Labs Celebrates 10 Years of Motiva Safety Data
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, is today announcing its latest clinical data demonstrating 10 years of...
Oct 07, 2020 04:45 pm ET
Establishment Labs to Celebrate 10 Years of Motiva Safety Data at Plastic Surgeon Virtual Symposium
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced it will host a virtual symposium on October 21, 2020 to present...
Sep 25, 2020 09:00 am ET
Establishment Labs Finalizes Distribution Agreement with Puregraft LLC
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced it has finalized an amendment to its distribution agreement with...
Sep 21, 2020 08:00 am ET
Establishment Labs Announces Independent Publication Detailing New Advancements in Hybrid Breast Reconstruction Technique Using Motiva Ergonomix Implants
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, announced today that a recently published independent study concluded that the...
Sep 02, 2020 08:00 am ET
ESTA Announces Participation in the Wells Fargo Virtual Healthcare Conference
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that CEO and Founder Juan José Chacón-Quirós and Chief Financial...
Aug 06, 2020 04:05 pm ET
Establishment Labs Announces Transition to a Direct Sales Force in Italy
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced it has entered into a definitive agreement with its Italian...
Aug 06, 2020 04:05 pm ET
Establishment Labs Reports Second Quarter 2020 Financial Results
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced its financial results for the second quarter ended June 30, 2020....
Jul 23, 2020 08:00 am ET
Establishment Labs to Announce Second Quarter 2020 Financial Results on August 6
Establishment Labs Holdings Inc. (Nasdaq: ESTA), a medical technology company focused on Women’s Health, initially in the breast aesthetics and reconstruction market, plans to announce its financial results for the quarter ended June 30, 2020 after...
Jun 11, 2020 08:00 am ET
Establishment Labs’ Motiva Flora Tissue Expander Receives CE Mark
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced it has received CE Mark for the Motiva Flora Tissue Expander....
Jun 03, 2020 08:00 am ET
ESTA Announces Participation in the Goldman Sachs Global Healthcare Conference
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that CEO and Founder Juan José Chacón-Quirós and Chief Financial...
May 26, 2020 08:00 am ET
ESTA Announces Participation in the Jefferies Virtual Healthcare Conference
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that CEO and Founder Juan José Chacón-Quirós and Chief Financial...
May 11, 2020 08:30 am ET
Establishment Labs Announces Participation in the UBS Virtual Global Healthcare Conference
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that CEO and Founder Juan José Chacón-Quirós and Chief Financial...
May 07, 2020 04:05 pm ET
Establishment Labs Reports Record First Quarter 2020 Financial Results
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced its financial results for the first quarter ended March 31, 2020....
Apr 23, 2020 08:00 am ET
Establishment Labs to Announce First Quarter 2020 Financial Results on May 7
Establishment Labs Holdings Inc. (Nasdaq: ESTA), a medical technology company focused on Women’s Health, initially in the breast aesthetics and reconstruction market, plans to announce its financial results for the quarter ended March 31, 2020...
Mar 25, 2020 09:00 am ET
Establishment Labs Receives Issuance for Key U.S. Patent Covering Company’s Implant Surface Technology
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that the U.S. Patent & Trademark Office has issued a patent...
Mar 16, 2020 08:00 am ET
Establishment Labs Reports Fourth Quarter and Full Year 2019 Financial Results
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced its financial results for the fourth quarter and full year ended...
Mar 03, 2020 08:00 am ET
Establishment Labs to Announce Fourth Quarter 2019 Financial Results on March 16
Establishment Labs Holdings Inc. (Nasdaq: ESTA) (the “Company”), a medical technology company focused on Women’s Health, initially in the breast aesthetics and reconstruction market, today announced the Company will release its financial results...
Feb 25, 2020 08:00 am ET
ESTA Announces Participation at the Cowen and Company 40th Annual Health Care Conference
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on Women’s Health – initially in the breast aesthetics and reconstruction market – today announced that CEO and Founder Juan José Chacón-Quirós will participate...
Feb 03, 2020 04:01 pm ET
Establishment Labs Announces Closing of Public Offering of Common Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Establishment Labs Holdings Inc. (Nasdaq: ESTA) (the “Company”), a medical technology company focused on Women’s Health – initially in the breast aesthetics and reconstruction market – today announced the closing of its previously announced public...
Jan 29, 2020 10:49 pm ET
Establishment Labs Announces Pricing of Public Offering of Common Shares
Establishment Labs Holdings Inc. (Nasdaq: ESTA) (the “Company”), a medical technology company focused on Women’s Health – initially in the breast aesthetics and reconstruction market – today announced the pricing of its public offering of 2,285,714...
Jan 28, 2020 04:05 pm ET
Establishment Labs Announces Preliminary Results for Fourth Quarter and Full Year 2019; Reports Record Revenue
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on Women’s Health – initially in the breast aesthetics and reconstruction market – today announced preliminary financial results for the fourth quarter and full...
Jan 28, 2020 04:01 pm ET
Establishment Labs Announces Proposed Public Offering of Common Shares
Establishment Labs Holdings Inc. (Nasdaq: ESTA) (the “Company”), a medical technology company focused on Women’s Health – initially in the breast aesthetics and reconstruction market – today announced that it has commenced a public offering of...
Dec 05, 2019 04:05 pm ET
ESTA Reaches One Million Motiva Implants Milestone
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on Women’s Health – initially in the breast aesthetics and reconstruction market – announced its one millionth Motiva® implant in market. Juan José...
Nov 12, 2019 07:00 am ET
Establishment Labs Reports Third Quarter 2019 Financial Results
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced its financial results for the third quarter ended September 30,...
Nov 07, 2019 04:01 pm ET
Establishment Labs is Presenting at Two November Investor Conferences
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that CEO and Founder Juan José Chacón-Quirós will participate at...
Oct 29, 2019 08:00 am ET
Establishment Labs to Announce Third Quarter 2019 Financial Results on November 12, 2019
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced the Company will release its financial results for the third...
Oct 22, 2019 08:00 am ET
Establishment Labs Recaps Fifth Annual World Symposium on Ergonomic Implants
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today provided a recap of the Fifth Annual World Symposium on Ergonomic Implants,...
Sep 16, 2019 10:06 am ET
Establishment Labs Receives Notice of Allowance for Key U.S. Patent Application Covering Company’s Implant Surface Technology and Announces 510(k) Submission for its Tissue Expander
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that the Company has received a Notice of Allowance from the U.S....
Aug 28, 2019 04:05 pm ET
Establishment Labs to Participate in the Morgan Stanley 17th Annual Global Healthcare Conference
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that CEO and Founder Juan José Chacón-Quirós will participate in...
Aug 13, 2019 08:00 am ET
Establishment Labs Reports Second Quarter 2019 Financial Results
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced its financial results for the second quarter ended June 30, 2019....
Jun 17, 2019 09:11 pm ET
Establishment Labs Announces Additional Financing and Improved Terms with Amendment to Existing Credit Agreement
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced it has entered into an amendment to its existing credit agreement...
Jun 06, 2019 04:05 pm ET
Establishment Labs Announces Appointment of Lisa Gersh to Board of Directors
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced the appointment of Lisa Gersh to its Board of Directors,...
May 22, 2019 04:55 pm ET
ESTABLISHMENT LABS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Establishment Labs Holdings Inc. To Contact The Firm
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Establishment Labs Holdings Inc. ("Establishment Labs" or the "Company")(NASDAQ:ESTA). If you invested in Establishment Labs stock or...
May 22, 2019 08:00 am ET
Establishment Labs Holdings Inc. and Allergan Sales, LLC Extend Distribution and Supply Agreement for MotivaImagine® Insertion Sleeve
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced it has reached an agreement with Allergan Sales, LLC to extend an...
May 20, 2019 05:50 pm ET
Glancy Prongay & Murray LLP Announces Investigation on Behalf of Establishment Labs Holdings Inc. Investors (ESTA)
Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of Establishment Labs Holdings Inc. (“Establishment Labs” or the “Company”) (NASDAQ: ESTA) investors concerning the Company and its officers’ possible violations of federal securities laws.
May 20, 2019 08:00 am ET
Establishment Labs to Present at Jefferies 2019 Healthcare Conference
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that Chief Executive Officer Juan José Chacón-Quirós will be...
May 17, 2019 06:31 pm ET
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Establishment Labs Holdings Inc. Investors (ESTA)
Law Offices of Howard G. Smith announces an investigation on behalf of Establishment Labs Holdings Inc. (“Establishment Labs” or the “Company”) (NASDAQ: ESTA) investors concerning the Company and its officers’ possible violations of federal securities laws.
May 17, 2019 05:13 pm ET
ESTABLISHMENT LABS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Establishment Labs Holdings Inc. To Contact The Firm
NEW YORK, May 17, 2019 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Establishment Labs Holdings Inc. ("Establishment Labs" or the "Company")(NASDAQ:ESTA).
May 17, 2019 11:17 am ET
EQUITY ALERT: Rosen Law Firm Continues to Investigate Securities Claims Against Establishment Labs Holdings Inc.; Investors are Encouraged to Contact the Firm
Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Establishment Labs Holdings Inc. (NASDAQ:ESTA) resulting from allegations that Establishment Labs may have issued materially misleading business information to the investing public.
May 15, 2019 08:00 am ET
Establishment Labs Reports First Quarter 2019 Financial Results
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced its financial results for the first quarter ended March 31, 2019....
Apr 26, 2019 08:00 am ET
Establishment Labs to Present at UBS Global Healthcare Conference
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that CEO and Founder Juan José Chacón-Quirós will be presenting...
Apr 24, 2019 08:30 am ET
Establishment Labs to Announce First Quarter 2019 Financial Results
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced the Company will release its financial results for the first...
Apr 15, 2019 10:15 am ET
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Establishment Labs Holdings Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Establishment Labs Holdings Inc. (“Establishment Labs” or “the Company”) (NASDAQ: ESTA) for violations of...
Apr 11, 2019 10:32 pm ET
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Establishment Labs Holdings Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Establishment Labs Holdings Inc. (“Establishment Labs” or “the Company”) (NASDAQ:
Apr 10, 2019 08:00 pm ET
Bragar Eagel & Squire, P.C. is Investigating Establishment Labs Holdings Inc. (ESTA) on Behalf of Stockholders and Encourages ESTA Investors to Contact the Firm
Bragar Eagel & Squire, P.C. is investigating potential claims against Establishment Labs Holdings Inc. (NASDAQ: ESTA).  Our investigation concerns whether Establishment Labs has violated the federal securities laws and/or engaged in other unlawful...
Apr 10, 2019 05:32 pm ET
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Establishment Labs Holdings Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Establishment Labs Holdings Inc. (“Establishment Labs” or “the Company”) (NASDAQ:
Apr 10, 2019 11:22 am ET
EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Establishment Labs Holdings Inc. – ESTA
Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Establishment Labs Holdings Inc. (NASDAQ: ESTA) resulting from allegations that Establishment Labs may have issued materially misleading business information to the investing public.
Apr 10, 2019 10:22 am ET
Establishment Labs Investigated by Block & Leviton LLP For Violations of Federal Securities Laws
Block & Leviton LLP (www.blockesq.com), a securities litigation firm representing investors nationwide, is investigating whether Establishment Labs Holdings Inc. (“Establishment Labs” or the “Company”) (NASDAQ: ESTA) and certain of its officers and...
Mar 20, 2019 04:01 pm ET
Establishment Labs Reports Fourth Quarter and Full Year 2018 Financial Results
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced its financial results for the fourth quarter and full year ended...
Mar 01, 2019 08:30 am ET
Establishment Labs to Present at the Cowen 39th Annual Health Care Conference
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on improving patient safety and aesthetic outcomes, initially in the breast aesthetics and reconstruction market, today announced that CEO and Founder Juan José...
Feb 25, 2019 08:30 am ET
Establishment Labs to Announce Fourth Quarter and Full Year 2018 Financial Results
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on improving patient safety and aesthetic outcomes, initially in the breast aesthetics and reconstruction market, today announced the Company will release its...
Nov 13, 2018 07:00 am ET
Establishment Labs Reports Third-Quarter 2018 Financial Results
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on improving patient safety and aesthetic outcomes, initially in the breast aesthetics and reconstruction market, today announced its financial results for the...
Nov 05, 2018 08:00 am ET
Establishment Labs to Present at Jefferies 2018 London Healthcare Conference
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on improving patient safety and aesthetic outcomes, initially in the breast aesthetics and reconstruction market, today announced that Juan José Chacón-Quirós,...
Nov 01, 2018 08:00 am ET
Establishment Labs to Release Third Quarter 2018 Financial Results on November 13, 2018
Establishment Labs Holdings Inc. (NASDAQ: ESTA) today announced that the Company will release its third quarter 2018 financial results on Tuesday, November 13, 2018, prior to the open of U.S. financial markets. Establishment Labs will host a...
Oct 04, 2018 08:00 am ET
Establishment Labs Announces Transition to a Direct Sales Force in Germany and Spain During its 4th Annual World Symposium on Ergonomic Implants
Establishment Labs Holdings, Inc. (NASDAQ: ESTA), a medical technology company focused on improving patient safety and aesthetic outcomes, initially in the breast aesthetics and reconstruction market, announced today at the Annual World Symposium...
Sep 04, 2018 08:00 am ET
Establishment Labs announces transition to a Direct Sales Force in the United Kingdom
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on improving patient safety and aesthetic outcomes, initially in the breast aesthetics and reconstruction market, announced today that it is transitioning,...
Aug 14, 2018 07:00 am ET
Establishment Labs Reports Second Quarter 2018 Financial Results
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on improving patient safety and aesthetic outcomes, initially in the breast aesthetics and reconstruction market, reported financial results for the second...
Aug 07, 2018 08:00 am ET
Establishment Labs to Release Second Quarter 2018 Financial Results on August 14, 2018
Establishment Labs (NASDAQ: ESTA) today announced that the Company will release its second quarter 2018 financial results on Tuesday, August 14, 2018, prior to the open of U.S. financial markets. Establishment Labs will host a conference call and...
Jul 23, 2018 04:05 pm ET
Establishment Labs Announces Closing of Initial Public Offering and Exercise in Full of Underwriters' Option to Purchase Additional Common Shares
Establishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company focused on breast aesthetics and reconstruction technologies, today announced the closing of its initial public offering of 4,272,568 common shares, including the...
Jul 19, 2018 11:52 am ET
Establishment Labs Celebrates Initial Public Offering on the Nasdaq Stock Market
Establishment Labs Holdings Inc. (NASDAQ:ESTA) today announced that the company’s common stock commenced trading on the Nasdaq Stock Market under the trading symbol “ESTA” following its initial public offering. Establishment Labs is a global...
Jul 18, 2018 09:36 pm ET
Establishment Labs Announces Pricing of Initial Public Offering
Establishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company focused on breast aesthetics and reconstruction technologies, today announced the pricing of its initial public offering of 3,715,277 common shares at a public...

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.